scPharmaceuticals

United States
Altona, Illinois, United States, 02421

Company profile

scPharmaceuticals company profile

ScPharmaceticals is creating innovative and important new therapeutic options by administering drugs subcutaneously using a convenient two-component delivery system suitable for patient self-administration. In February 2013 scPharmaceuticals was formed to continue the groundbreaking work of SpringLeaf Therapeutics, a Boston area company that started in 2007. scPharmaceuticals targets the untapped opportunity of treating patients with serious medical conditions with a convenient safe and comfortable subcutaneous administration of a drug. This is therapeutically equivalent to intravenous administration while avoiding the cost, burden, and risks associated with intravenous administration.

Business identity

Contact email
[email protected]
Phone number
(617)517-0730
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$1M-$10M
Founded
2014-01-01, Year

Headquarters

Postal code
02421
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
8
Total equity funding
$211.6M
Last funding
Post IPO Debt / $125M / 2024-08-12
Last equity funding
Post IPO Equity / $50M
Investors
8
Lead investors
8
Founders
1
Articles
125
Exited on
2017-11-17

Founders and investors

Founders

Pieter Muntendam

Lead investors

5AM VenturesLundbeckfonden VenturesOaktree Capital ManagementOrbiMedPerceptive AdvisorsSilicon Valley BankSolar capitalSun Pharmaceutical Industries

Investors

5AM VenturesOaktree Capital ManagementOrbiMedPerceptive AdvisorsSilicon Valley Bank